You are here

Article Text

Article menu
Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF α therapy for chronic plaque psoriasis
  1. Zahra Ahmed1,
  2. Robert Powell2,
  3. Gareth Llewelyn2,
  4. Alex Anstey3
  1. 1Dermatology Department, University Hospital Wales, Cardiff, UK
  2. 2Neurology Department, Royal Gwent Hospital, Newport, UK
  3. 3Dermatology Department, Royal Gwent Hopital, Newport, UK
  1. Correspondence to Dr Zahra Ahmed, zahra1{at}doctors.org.uk

Summary

A 53-year-old woman with chronic plaque psoriasis treated with adalimumab (antitumour necrosis factor (anti TNF) α therapy) for 10 months presented with an 8 week history of hyperesthesia in a ‘glove and stocking’ distribution and clumsiness on walking. Nerve conduction studies confirmed the clinical diagnosis of a chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). She was admitted and treated with intravenous immunoglobulin and oral steroids and made an excellent recovery. To our knowledge, this is the first published report of CIDP associated with anti TNF α therapy given to treat psoriasis.

https://doi.org/10.1136/bcr.08.2011.4674

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests None.

    • Patient consent Obtained.